AS‐TLC‐Based High‐Throughput Screening Integrated with CuAAC Optimization Strategy Facilitates the Rapid Discovery of YTHDC1 Inhibitor
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.08.2026. Verfasst von Mingchen Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Drug Discovery, RNA Splicing Factors. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The classical sequential workflow—individual compound screening, followed by stepwise design‐synthesis‐purification of derivatives—makes lead compound discovery time‐consuming and cost‐prohibitive. Herein, we developed Affinity Selection Thin‐Layer Chromatography (AS‐TLC) as a method for high‐throughput screening (HTS), enabling efficient and cost‐effective screening of compound mixtures. Furthermore, we integrated activity assays with AS‐TLC to minimize target protein consumption and lower the false positive rate, through which we identified a YTH domain‐containing protein 1 (YTHDC1) inhibitor, fragment YD, with a half‐maximal inhibitory concentration (IC 50 ) of 20.01 ± 3.30 µ m . Building on this hit, we applied copper(I)‐catalyzed azide–alkyne cycloaddition (CuAAC) click chemistry for rapid structural modification and compound library construction, ultimately obtaining LC‐YD03 with significantly enhanced inhibitory activity (IC 50 = 41.98 ± 6.24 n m ). The interaction mode between LC‐YD03 and YTHDC1 was further clarified via X‐ray crystallographic analysis. This study demonstrates that the AS‐TLC‐activity assay platform enables efficient hit screening from compound mixtures; subsequent click chemistry‐based combinatorial library technology accelerates lead compound optimization. Collectively, this workflow significantly reduces the time and cost associated with lead compound discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
- Precision Medicine Research Institute of Guizhou, and Guizhou Provincial Key Laboratory of Digestive System Diseases, The Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guiyang, China.
- Innovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, Shanghai, China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China.
ORCID-Profile: Chujiao Hu, Huan Xiong, Cheng Luo, Shijie Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Science and Technology Commission of Shanghai Municipality
- Zhongshan Municipal Bureau of Science and Technology
- Science and Technology Department of Guizhou Province
- Major Program of Guangzhou National Laboratory
- Tianfu Jincheng Laboratory
Zitieren
APA
Wang, M., Fu, S., Xu, Y., Gao, J., Ren, J., Yang, X., Xu, H., Sun, G., Li, Y., Wang, Y., Jin, L., Chen, P., Xu, Y., Li, J., Lin, H., Hu, C., Chen, K., Xiong, H., Luo, C., & Chen, S. (2026). AS‐TLC‐Based High‐Throughput Screening Integrated with CuAAC Optimization Strategy Facilitates the Rapid Discovery of YTHDC1 Inhibitor. Advanced Science, 13(63). https://doi.org/10.1002/advs.77386
Vancouver
Wang M, Fu S, Xu Y, Gao J, Ren J, Yang X, et al. AS‐TLC‐Based High‐Throughput Screening Integrated with CuAAC Optimization Strategy Facilitates the Rapid Discovery of YTHDC1 Inhibitor. Advanced Science. 2026;13(63). doi:10.1002/advs.77386
BibTeX
@article{Wang2026,
author = {Wang, Mingchen and Fu, Shuiping and Xu, Ye and Gao, Jia and Ren, Jiwei and Yang, Xu and Xu, Hesong and Sun, Ge and Li, Yanjie and Wang, Yanlin and Jin, Lu and Chen, Peijuan and Xu, Ying and Li, Jianhao and Lin, Hua and Hu, Chujiao and Chen, Kaixian and Xiong, Huan and Luo, Cheng and Chen, Shijie},
title = {AS‐TLC‐Based High‐Throughput Screening Integrated with CuAAC Optimization Strategy Facilitates the Rapid Discovery of YTHDC1 Inhibitor},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77386}
}
EUVIMED